Skip to Main Content

Author Details

Eric C Kleerup
university of california los angeles
1989
87
39
PMIDPaper TitleJournal TitlePublished Year
34103907Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).Int J Chron Obstruct Pulmon Dis2021
30653926Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy.Ann Am Thorac Soc2019
31233743Gene Expression Alterations in the Bronchial Epithelium of e-Cigarette Users.Chest2019
31307479Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS).Respir Res2019
31113229Lung Function, Coronary Artery Disease, and Mortality in HIV.Ann Am Thorac Soc2019
29339516Human airway branch variation and chronic obstructive pulmonary disease.Proc Natl Acad Sci U S A2018
30068317Genome-wide association study of lung function and clinical implication in heavy smokers.BMC Med Genet2018
29983746Measuring associations between the microbiota and repeated measures of continuous clinical variables using a lasso-penalized generalized linear mixed model.BioData Min2018
30227877Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).Respir Res2018
30142142Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals.J Acquir Immune Defic Syndr2018
30454050Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.Respir Res2018
30286195Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation.PLoS One2018
29534240Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS).Sleep2018
29335027Fungi stabilize connectivity in the lung and skin microbial ecosystems.Microbiome2018
29313714Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.Ann Am Thorac Soc2018
27579823Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.Am J Respir Crit Care Med2017
28459622Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.Ann Am Thorac Soc2017
28453572Assessment of coronary artery calcium by chest CT compared with EKG-gated cardiac CT in the multicenter AIDS cohort study.PLoS One2017
29435345Differentiation of quantitative CT imaging phenotypes in asthma versus COPD.BMJ Open Respir Res2017
28934249Variability in objective and subjective measures affects baseline values in studies of patients with COPD.PLoS One2017
29146301Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.Lancet Respir Med2017
27701119Molecular Impact of Electronic Cigarette Aerosol Exposure in Human Bronchial Epithelium.Toxicol Sci2017
27941393Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease.AIDS2017
27884601Evaluating small-airways disease in asthmatic patients: The utility of quantitative computed tomography.J Allergy Clin Immunol2017
25452309Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.Ann Rheum Dis2016
27532455Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.PLoS Genet2016
27168432Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.N Engl J Med2016
27469583Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.Lancet Respir Med2016
26990629Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.AIDS2016
26757749Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.Ann Rheum Dis2016
25517700Differences between attendings' and fellows' perceptions of futile treatment in the intensive care unit at one academic health center: implications for training.Acad Med2015
26372280Factors associated with abnormal spirometry among HIV-infected individuals.AIDS2015
26056194Medicare Payment Policy Creates Incentives For Long-Term Care Hospitals To Time Discharges For Maximum Reimbursement.Health Aff (Millwood)2015
25603113Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.Am J Respir Crit Care Med2015
24029743Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).Thorax2014
25664201Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy.J AIDS Clin Res2014
25175805Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.Respir Res2014
24810527The opportunity cost of futile treatment in the ICU*.Crit Care Med2014
24746752Assessing the validity of the RAND negative impact of asthma on quality of life short forms.J Allergy Clin Immunol2014
24928812Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).Thorax2014
24884738Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts.BMC Pulm Med2014
24559465Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.Am J Respir Crit Care Med2014
24397870Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.J Transl Med2014
23491408Comparison of the respiratory microbiome in healthy nonsmokers and smokers.Am J Respir Crit Care Med2013
24083651Factors associated with palliative withdrawal of mechanical ventilation and time to death after withdrawal.J Palliat Med2013
24018712The frequency and cost of treatment perceived to be futile in critical care.JAMA Intern Med2013
23979001HIV infection is associated with reduced pulmonary diffusing capacity.J Acquir Immune Defic Syndr2013
23979000HIV infection is associated with diffusing capacity impairment in women.J Acquir Immune Defic Syndr2013
23972968Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.Respir Med2013
23554932The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.PLoS One2013
  • 1 - 50 of 87

Recommended Authors

Mayo Clinic Florida
Career Start Year 2016
Number of shared co-authors 0
University of Alabama at Birmingham Heersink School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of Alabama Heersink School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Hospital Universitario de La Princesa
Career Start Year 2013
Number of shared co-authors 0
Amsterdam University Medical Centers
Career Start Year 2012
Number of shared co-authors 1
State University of New York at Buffalo
Career Start Year 2011
Number of shared co-authors 3
The Second Affiliated Hospital of Xiamen Medical College
Career Start Year 2011
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 2
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 3
Pendik Research and Training Hospital, Marmara University
Career Start Year 2003
Number of shared co-authors 2
University of New Mexico
Career Start Year 2003
Number of shared co-authors 3
University of Colorado School of Medicine
Career Start Year 2002
Number of shared co-authors 5
Institute of Inflammation and Ageing, University of Birmingham
Career Start Year 2000
Number of shared co-authors 0
College of Medicine, University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1994
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 2
Hospital Muri
Career Start Year 1992
Number of shared co-authors 0
Medical College of Wisconsin
Career Start Year 1987
Number of shared co-authors 4
University of Texas Health
Career Start Year 1986
Number of shared co-authors 6
Nottingham NIHR Biomedical Research Centre
Career Start Year 1986
Number of shared co-authors 0
Hospital del Mar - IMIM
Career Start Year 1984
Number of shared co-authors 1
Instituto de Salud Carlos III, Hospital Universitario La Princesa
Career Start Year 1984
Number of shared co-authors 0
Kunming University of Science and Technology
Career Start Year 1984
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1983
Number of shared co-authors 2
National Jewish Health
Career Start Year 1977
Number of shared co-authors 4
Columbia University Medical Center
Career Start Year 1977
Number of shared co-authors 3
University of California san francisco
Career Start Year 1972
Number of shared co-authors 6
The University of California San Diego
Career Start Year 1972
Number of shared co-authors 5
University of Wisconsin School of Medicine and Public Health
Career Start Year 1968
Number of shared co-authors 10

Collaborators

Co-authored papers 17
Co-authored papers 15
Co-authored papers 14
David Geffen School of Medicine at university of california los angeles
Co-authored papers 12
Co-authored papers 10
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 5
Co-authored papers 4
University of California los angeles
Co-authored papers 4
University of Pittsburgh School of Public Health
Co-authored papers 3
University of California los angeles
Co-authored papers 3
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Graduate School of Public Health, University of Pittsburgh
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Co-authored papers 2
Boston University School of Medicine
Co-authored papers 2
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
University of California San Diego
Co-authored papers 2
Co-authored papers 2
Lundquist Institute at Harbor university of california los angeles Medical Center
Co-authored papers 2
David Geffen School of Medicine at University of California los angeles
Co-authored papers 2
University of Illinois at Chicago
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Boston University School of Medicine
Co-authored papers 2